What are Regulatory Affairs?
Regulatory Affairs in the Pharmaceutical industry, is a profession that acts as the interface between the pharmaceutical industry and Drug Regulatory authorities across the world. It is mainly involved in the registration of drug products in respective countries prior to their marketing.
What are the goals of Regulatory Affairs Professionals?
- Protection of human health
- Ensuring safety, efficacy and quality of drugs
- Ensuring appropriateness and accuracy of product information
What are the Roles of Regulatory Affairs professionals?
- Act as a liaison with regulatory agencies
- Preparation of organized and scientifically valid NDA, ANDA, INDA, MAA, and DMF submissions
- Ensure adherence and compliance with all the applicable cGMP, ICH, GCP, GLP guidelines, regulations, and laws
- Providing expertise and regulatory intelligence in translating regulatory requirements into practical workable plans
- Advising the companies on regulatory aspects and climate that would affect their proposed activities
- Apart from the above main roles, there are various other roles that Regulatory Affairs professionals play.
- Keeping track of the ever-changing legislation in all the regions in which a company wishes to distribute its products.
- Advising on legal and scientific restraints and requirements.
- Collecting, collating, and evaluating scientific data.
- Presenting registration documents to regulatory agencies and carrying out any subsequent negotiations necessary to obtain or maintain marketing authorization for the products concerned.
- Giving strategic and technical advice at the highest level in their companies, making animportant contribution both commercially and scientifically to the success of adevelopment programme and the company as a whole.
- Helping the company avoid problems caused by badly kept records, inappropriate scientific thinking or poor presentation of data.
What is an Investigational New Drug (IND) application?
It is an application that is filed with FDA to get approval for legally testing an experimental drug on human subjects in the USA.
What is a New Drug Application?
The NDA is the vehicle through which drug sponsors formally propose that the FDA approve a new pharmaceutical for sale and marketing in the U.S. The data gathered during the animal studies and human clinical trials of an Investigational new drug become part of the NDA. In simple words, “It is an application which is filed with FDA to market a new Pharmaceutical for sale in USA”
What is an Abbreviated New Drug Application (ANDA)?
It is an application filed with FDA, for a U.S. generic drug approval for an existing licensed medication or approved drug. In simple words, “It is an application for the approval of Generic Drugs “
What is a Generic Drug Product?
A generic drug product is one that is comparable to an innovator drug product in dosage form, strength, route of administration, quality, performance characteristics and intended use.
What is a DMF?
A Drug Master File (DMF) is a submission to the Food and Drug Administration (FDA) that may be used to provide confidential detailed information about facilities, processes, or articles used in the manufacturing, processing, packaging, and storing of one or more human drugs.
Important facts regarding DMFs
- It is submitted to FDA to provide confidential information
- Its submission is not required by law or regulations
- It is neither approved nor disapproved
- It is filed with FDA to support NDA, IND, ANDA another DMF or amendments and supplements to any of these
- It is provided for in the 21 CFR (Code of Federal Regulations) 314. 420
- It is not required when the applicant references its own information
What are the types of DMF’s?
Type I: Manufacturing Site, Facilities, Operating Procedures, and Personnel (No longer accepted by FDA)
Type II: Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
Type III: Packaging Material
Type IV: Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
Type V: FDA Accepted Reference Information (FDA discourages its use)
What is a 505 (b)(2) application?
505 (b)(2) application is a type of NDA for which one or more investigations relied on by the applicant for approval were not conducted by/for the applicant and for which the applicant has not obtained a right of reference.
What kind of application can be submitted as a 505(b)(2) application?
New chemical entity (NCE)/new molecular entity (NME)
Changes to previously approved drugs
What are the examples of changes to approved drug products for which 505(b)(2) applications should be submitted?
- Change in the dosage form.
- Change in strength
- Change in route of administration
- Substitution of an active ingredient in a formulation product
- Change in formulation
- Change in dosing regimen
- Change in active ingredient
- New combination Product
- New Indication
- Change from prescription indication to OTC indication
- Naturally derived or recombinant active ingredient
- Bioequivalence
What are the chemical classification codes for NDA?
Number
|
Meaning
|
1
|
New
molecular entity (NME)
|
2
|
New
ester, new salt, or other noncovalent derivatives
|
3
|
New
formulation
|
4
|
New
combination
|
5
|
New
manufacturer
|
6
|
New
Indication
|
7
|
The drug is already marketed, but without an approved NDA
|
8
|
OTC
(over-the-counter) switch
|
What are the differences between NDA and 505 (b)(2) application?
Sr. No.
|
New Drug Application (NDA)
|
505 (b)(2) Application
|
1.
|
All
investigations relied on by the applicant for approval were conducted by/for the applicant and for which applicant has right of reference
|
One
or more investigations relied on by the applicant for approval were not conducted by/for the applicant and for which the applicant has not obtained a right of reference
|
2.
|
Generally,
filed for newly invented pharmaceuticals.
|
Generally,
filed for new dosage forms, new routes of administration, new indications, etc.
for all already approved pharmaceuticals.
|
Note: 505 (b)(2) application is a type of NDA.
What is a Marketing Authorization Application?
It is an application filed with the relevant authority in Europe (typically, the UK's MHRA or the EMA’s Committee for Medicinal Products for Human Use (CHMP)) to market a drug or medicine.
As per UK’s MHRA-
- Applications for new active substances are described as 'full applications.
- Applications for medicines containing existing active substances are described as 'abbreviated’ or ‘abridged applications’.
What is an ASMF?
An active substance master file is a submission that is made to EMA, MHRA, or any other Drug Regulatory Authority in Europe to provide the confidential intellectual property or 'know-how' of the manufacturer of the active substance.
In simple words, “It is a submission made to European Drug regulatory agencies on the confidential information of Active Substance or Active Pharmaceutical Ingredient (API)”.
What are the types of active substances for which ASMFs are submitted?
- New active substances
- Existing active substances not included in the European Pharmacopoeia (Ph. Eur.) or the pharmacopeia of an EU Member State
- Pharmacopeial active substances included in the Ph. Eur. or in the pharmacopeia of an EU Member State
What is the difference between DMF and ASMF (with respect to submission)?
ASMF is submitted as Applicant’s Part (Open Part) and Restricted Part (Closed Part)
There isn’t any differentiation of DMF’s into parts
What is ICH?
International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH): is a project that brings together the regulatory authorities of Europe, Japan and the United States and experts from the pharmaceutical industry in the three regions to discuss scientific and technical aspects of pharmaceutical product registration.
What is CTD?
The Common Technical Document (CTD) is a set of specifications for the application dossier, for the registration of Medicines and is designed to be used across Europe, Japan, and the United States. Quality, Safety, and Efficacy information are assembled in a common format through CTD. The CTD is maintained by the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH).
CTD format for submission of drug registration applications/dossiers is widely accepted by regulatory authorities of other countries too like Canada, Australia etc.
What are the ICH guidelines to be referred for the preparation of registration dossiers/applications of medicines (With respect to format and contents in each module)?
M4 Guideline M4Q Guideline M4S Guideline M4E Guideline
What are the modules in CTD?
The Common Technical Document is divided into five modules:
- Module 1. Administrative information and prescribing information
- Module 2. Common Technical Document summaries (Overview and summary of modules 3 to 5)
- Module 3. Quality
- Module 4. Nonclinical Study Reports (toxicology studies)
- Module 5. Clinical Study Reports (clinical studies)
What is Orange Book?
It is the commonly used name for the book “Approved Drug Products with Therapeutic Equivalence Evaluations”, which is published by USFDA.
It contains the list of drug products, approved on the basis of safety and effectiveness by the Food and Drug Administration (FDA) under the Federal Food, Drug, and Cosmetic Act.
What is Hatch-Waxman act?
It is the popular name for Drug Price Competition and Patent Term Restoration Act, 1984. It is considered the landmark legislation which established the modern system of generic drugs in the USA. Hatch-Waxman amendment of the federal food, drug, and cosmetics act established the process by which, would-be marketers of generic drugs can file an Abbreviated New Drug Application (ANDA) to seek FDA approval of generic drugs. Paragraph IV of the act allows 180-day exclusivity to companies that are the "first-to-file" an ANDA against holders of patents for branded counterparts.
In simple words “Hatch-Waxman act is the amendment to Federal, Food, Drug and Cosmetics act which established the modern system of approval of generics ”
What are the patent certifications under the Hatch-Waxman act?
As per the Hatch and Waxman act, generic drug and 505 (b) (2) applicants should include certifications in their applications for each patent listed in the “Orange Book” for the innovator drug. This certification must state one of the following:
- that the required patent information relating to such patent has not been filed (Para I certification);
- that such patent has expired (Para II certification);
- that the patent will expire on a particular date (Para III certification); or
- that such patent is invalid or will not be infringed by the drug, for which approval is being sought(Para IV certification).
A certification under paragraph I or II permits the ANDA to be approved immediately if it is otherwise eligible. A certification under paragraph III indicates that the ANDA may be approved when the patent expires.
What is meant by 180-day exclusivity?
The Hatch-Waxman Amendments provide an incentive of 180 days of market exclusivity to the “first” generic applicant who challenges a listed patent by filing a paragraph IV certification and thereby runs the risk of having to defend a patent infringement suit.
180-Day Exclusivity could be granted to more than one applicant. A recent example is- 180-day exclusivity was granted to Ranbaxy and Watson Laboratories for marketing a generic version of Lipitor (Atorvastatin calcium).
What are the procedures for the Approval of Drugs in the EU?
Centralized Procedure (CP) Decentralised Procedure (DCP)
Mutual Recognition Procedure (MRP) National Procedure (NP)
What is the Full form of abbreviation, CEP?
Certificate of Suitability to the monographs of the European Pharmacopoeia (or) Certificate of suitability of monographs of the European Pharmacopoeia (or) Certification of the suitability of European Pharmacopoeia monographs.
It is also informally referred to as the Certificate of Suitability (COS)
What is a CEP?
It is the certificate which is issued by the Certification of Substances Division of the European Directorate for the Quality of Medicines (EDQM), when the manufacturer of a substance provides proof that the quality of the substance is suitably controlled by the relevant monographs of the European Pharmacopoeia.
Full forms of some of the Abbreviations related to Regulatory Affairs
Sr. No.
|
Abbreviation
|
Full Form
|
1
|
NDA
|
New
Drug Application
|
2
|
ANDA
|
Abbreviated
New Drug application
|
3
|
IND
|
Investigational
New Drug Application
|
4
|
DMF
|
Drug
Master file
|
5
|
ASMF
|
Active
Substance Master File
|
6
|
MAA
|
Marketing
Authorization Application
|
7
|
CEP
|
Certificate
of Suitability to the monographs of the European Pharmacopoeia
|
8
|
ICH
|
The
International Conference on Harmonisation of technical requirements for registration
of Pharmaceuticals for human use.
|
9
|
CTD
|
Common
technical document for the registration of pharmaceuticals for human use.
|
10
|
AP
|
Applicant’s
Part
|
11
|
RP
|
Restricted
Part
|
12
|
OP
|
Open
Part
|
13
|
CP
|
Closed
Part
|
14
|
NME
|
New
Molecular Entity
|
15
|
NCE
|
New
Chemical Entity
|
16
|
SmPC
|
Summary
of Product Characteristics
|
17
|
PL
|
Packaging
Leaflet
|
18
|
RMS
|
Reference
Member State
|
19
|
CMS
|
Concerned
Member State
|
20
|
CHMP
|
The
Committee for Medicinal Products for Human Use
|
21
|
CPMP
|
Committee
for Proprietary Medicinal Products
|
22
|
CVMP
|
Committee
For Medicinal Products For Veterinary Use
|
23
|
SUPAC
|
Scale-up
and post-approval changes
|
24
|
BACPAC
|
Bulk
Active Chemicals Post-approval Changes
|
25
|
cGMP
|
Current
Good Manufacturing Practice
|
26
|
GCP
|
Good
Clinical Practice
|
27
|
GLP
|
Good
Laboratory Practice
|
Well-known Drug Regulatory Agencies across the world
Sr. No.
|
Country /Region
|
Regulatory Agency
|
1
|
United
States of America
|
United
States Food and Drug Administration (USFDA)
|
2
|
United
Kingdom
|
Medicines
and Healthcare products Regulatory Agency (MHRA)
|
3
|
European
Union
|
European
Medicines Agency (EMA)
|
4
|
European
Union
|
European
Directorate for the Quality of Medicines (EDQM)
|
5
|
Australia
|
Therapeutic
Goods Administration (TGA)
|
6
|
Canada
|
Therapeutic
Products Directorate (TPD) in Health Product and food branch (HPFB) of Health
Canada (HC)
|
7
|
Japan
|
Pharmaceutical
and Medical Devices Agency (PMDA)
|
8
|
France
|
Agence
Francaise de Securite Sanitaire des Produits de Sante (AFSSAPS)
Translated
into English as- French Agency for the Safety of Health Products
|
9
|
Germany
|
Bundesinstitut
für Arzneimittel und Medizinprodukte, (BfArM)
Tanslated
into English as- Federal Institute for Drugs and Medical Devices
|
10
|
Brazil
|
Agência
Nacional de Vigilância Sanitária (ANVISA)
Tanslated
into English as- The National Health Surveillance Agency
|
11
|
India
|
Drugs
Controller General of India (DCGI) who heads Central Drugs Standard Control
Organisation (CDSCO)
|
12
|
Switzerland
|
Swiss
Agency for Therapeutic Products (SWISSMEDIC)
|
14
|
Singapore
|
Health
Sciences Authority (HSA)
|
15
|
New
Zealand
|
New
Zealand Medicines and Medical Devices Safety Authority (MEDSAFE)
|
What is a dossier in pharma?
A registration Dossier of the pharmaceutical product is a document that contains all the technical data (administrative, quality, nonclinical and clinical) of a pharmaceutical product to be approved/registered/marketed in a country.
Who controls the CFR?
The CFR is divided into 50 titles that represent broad areas subject to federal regulation.
The CFR annual edition is the codification of the general and permanent rules published by the Office of the Federal Register (part of the National Archives and Records Administration) and the Government Publishing Office.
What does 510k mean?
A 510(K) is a premarket submission made to FDA to demonstrate that the device to be marketed is as safe and effective, that is, substantially equivalent, to a legally marketed device (section513(i)(1)(A) FD&C Act) that is not subject to premarket approval.
What percentage of drugs make it through clinical trials?
New MIT Study Puts Clinical Research Success Rate at 14 %. Nearly 14percent of all drugs in clinical trials eventually win approval from the FDA - a much higher percentage than previously thought, according to a new study from the MIT Sloan School of Management.
What are the 3 main GCP principles?
Three basic ethical principles of equal importance, namely respect for persons, beneficence, and justice, permeate all other GCP principles. Research involving humans should be scientifically justified and described in a clear, detailed protocol.
What are the three parts of a dossier?
Though there is no specifically recognized format, the teaching dossier typically consists of two basic components: a teaching narrative statement or philosophy, which is a short reflective narrative (two to three pages), and an appendix, which consists of supporting documentation.
How do I create a dossier?
To create a dossier. On the home page or any folder page, click Create, and then select new dossier. Your dossier is created and displayed, containing a single blank visualization. If the Getting Started page is displayed, click Get Started to open the dossier.
What is DMF in pharma?
Drug Master File or DMF is a document prepared by a pharmaceutical manufacturer and submitted solely at its discretion to the appropriate regulatory authority in the intended drug market. There is no regulatory requirement to file a DMF.
What is NeeS submission?
This Guidance Document is intended to assist pharmaceutical companies with the submission of regulatory information in electronic format to the National Competent Authorities in the EEA (hereafter referred to as NCAs). This document details the requirements for the submission of Non- eCTD electronic Submissions (NeeS).
What is FDA CFR?
The Code of Federal Regulations (CFR) is a codification of the general and permanent rules published in the Federal Register by the Executive departments and agencies of the Federal Government. Title 21 of the CFR is reserved for the rules of the Food and Drug Administration.
What are cGMP guidelines?
The cGMP regulations for drugs contain minimum requirements for the methods, facilities, and controls used in the manufacturing, processing, and packing of a drug product. The regulations make sure that a product is safe for use, and that it has the ingredients and strength it claims to have.
Does FDA regulate alcohol?
The Federal Alcohol Administration Act (FAA) regulates the interstate and foreign commerce of wine, spirits, and malt beverages and bestows general authority to oversee these products to the TTB. Despite this, the labeling of some beers and some wines are regulated by the FDA.
What is a regulatory risk?
Regulatory risk is the risk that a change in laws and regulations will materially impact a security, business, sector, or market.
Why is regulatory compliance?
Protects your company. The regulations are there for a reason – they help protect your business, your employees, and your customers. Failing to adhere to regulatory compliance requirements can open you up to risks beyond just fines.
What class of drug is crack?
Crack cocaine is a Schedule II substance under the Controlled Substances Act. Schedule II drugs, which include PCP and metham - phetamine, have a high potential for abuse.
Who are the members of ICH?
ICH is now constituted by 16 Members and 28 Observers, after the ICH Assembly in 2018 approved TFDA, Chinese Taipei as a new Regulatory Member, and MMDA, Moldova, NPRA, Malaysia, NRA, Iran, SCDMTE, Armenia and TİTCK, Turkey as new Observers.
Is dossier a French word?
“Dossier,” the French word for such a compendium of spine-labeled folders, was picked up by English speakers in the late 19th century. It comes from “dos,” the French word for “back,” which is in turn derived from “dorsum,” Latin for the back.
What is a research dossier?
The term dossier refers to the application materials used when applying for academic jobs. The career development center is available to review all aspects of your dossier with you when you are applying for academic jobs. Below is an overview of teaching portfolios and teaching, research, and personal statements.
What is a dossier in Micro strategy?
About Dossiers. A dossier is an interactive display that you can use to quickly and easily explore your business data. For example, you can: View visual representations of the data (called visualization) in the dossier to make the data easier to interpret.
What is node extension in eCTD?
Node Extension Node extensions are a way of providing extended organizational information in the eCTD. The node extension should be visualized as an extra heading in the CTD structure and should be displayed as such when the XML backbone is viewed.
Do natural products need FDA approval?
The law does not require cosmetic products and ingredients, except for color additives, to be approved by FDA before they go on the market. You are legally responsible for making sure your cosmetics are safe and properly labeled, in compliance with all the laws and regulations that apply to them.
What does CMC stand for in drug development?
CHEMISTRY, MANUFACTURING, AND CONTROL
Together, these processes are known in preclinical and clinical development as chemistry, manufacturing, and control (CMC). Many aspects of drug development focus on satisfying the regulatory requirements of drug licensing authorities.
What are ICH countries?
Regulatory Members
- ANVISA, Brazil.
- HSA, Singapore.
- MFDS, Republic of Korea.
- NMPA, China.
- TFDA, Chinese Taipei.
What is the regulatory authority in India for pharmaceutical companies?
The Central Drugs Standard Control Organisation (CDSCO) is the national regulatory body for Indian pharmaceuticals and medical devices and serves a parallel function to the European Medicines Agency of the European Union, the PMDA of Japan, the Food and DrugAdministration of the United States and the Medicines.
Will fish survive ICH?
Fish that survive mild infections can develop immunity. There are currently no drugs or chemicals that kill ICH while it resides in the fish skin or gills; they can only kill ICH when the parasite is in the water, and therefore all current therapies require a cyclical re-treatment program.
What is eCTD submission format?
eCTD. The Electronic Common Technical Document (eCTD) is the standard format for submitting applications, amendments, supplements, and reports to FDA's Center for Biologics Evaluation and Research (CBER) and Center for Drug Evaluation and Research(CDER).
What are FDA guidelines?
About FDA Guidances
Guidance documents represent the Agency’s current thinking on a particular subject. They do not create or confer any rights for or on any person and do not operate to bind FDA or the public.
Is the FDA a regulatory agency?
The Food and Drug Administration (FDA) is a government agency established in 1906 with the passage of the Federal Food and Drugs Act.
What is the difference between compliance and regulatory?
In general, compliance means conforming to a rule, such as a specification, policy, standard or law. Regulatory compliance describes the goal that organizations aspire to achieve in their efforts to ensure that they are aware of and take steps to comply with relevant laws, policies, and regulations.
What are the 7 classifications of drugs?
7 Drug Categories
- Central Nervous System (CNS) Depressants. CNS depressants slow down the operations of the brain and the body.
- CNS Stimulants.
- Hallucinogens.
- Dissociative Anesthetics.
- Narcotic Analgesics.
- Inhalants.
- Cannabis.
What is CTD format?
The Common Technical Document (CTD) is a set of specifications for an application dossier for the registration of Medicines and is designed to be used across Europe, Japan, and the United States. Quality (pharmaceutical documentation)
How is a dossier prepared in pharmaceutical products?
Abstract: Dossier is a collection of documents on the particular subjects. Any preparation of a pharmaceutical product for human use goes through the process of reviewing and assessing the dossier of the pharmaceutical product which contains details information about administrative, quality, non-clinical and clinical data.
What is a dossier file?
A dossier is a collection of papers or other sources, containing detailed information about a particular person or subject.
How are drugs regulated?
Drug regulation: The process of testing, developing, and marketing of medicines has to be regulated to protect the interests of the public. Major regulatory bodies include the Food & Drug Administration (FDA) in the US and the European Medicines Agency (EMA) in Europe.
What makes good regulatory affairs professionals?
They must be detail-oriented and able to develop realistic action plans as well as prioritize work activities - without these there are bound to be difficulties in keeping up with all the tasks
What is regulatory submission?
Regulatory submission is the process through which pharmaceutical companies submit information about their newly developed healthcare product to a regulatory agency for review. They can also submit their documentation seeking additional knowledge about their device.
What are the 4 stages of drug development?
Drug Development Phases
Phase 1: Discovery and Development.
Phase 2: Preclinical Research.
Phase 3: Clinical Research.
Phase 4: FDA Review.
Phase 5: FDA Post-Market Safety Monitoring.
What is CMC in regulatory affairs?
Chemistry, Manufacturing, and Controls (CMC) Regulatory Affairs (RA) are a specific area within RA that has the ultimate responsibility for providing CMC regulatory leadership and strategy required to achieve regulatory approvals.
What is the difference between CTD and Actd?
The ACTD consists of Parts I to IV which have subsections A to F whereas ICH-CTD has 5 Modules with subsections that are numbered. The administrative data of Part I is part of ACTD whereas Module-1 of ICH-CTD is purely country-specific.
What is dossier preparation?
Abstract: Dossier is a collection of documents on particular subjects. Any preparation of a pharmaceutical product for human use goes through the process of reviewing and assessing the dossier of a pharmaceutical product which contains details information about administrative, quality, non-clinical, and clinical data.
What are regulatory guidelines?
Regulatory Requirements mean all applicable laws, rules, regulations, orders, requirements, guidelines, interpretations, directives, and requests (whether or not having the force of law) from and of, and plans, memoranda and agreements with, any Regulatory Authority.
What are the examples of regulated drugs?
Examples of Schedule II narcotics include: hydromorphone (Dilaudid®), methadone (Dolophine®), meperidine (Demerol®), oxycodone (OxyContin®, Percocet®), and fentanyl (Sublimaze®, Duragesic®). Other Schedule II narcotics include: morphine, opium, codeine, and hydrocodone.
What needs FDA approval?
Which Products Need FDA Approval?
- Human and animal drugs.
- Medical biologics.
- Medical devices.
- Food (including animal food)
- Tobacco products.
- Cosmetics.
- Electronic products that emit radiation.
What are regulatory affairs in the pharmaceutical industry?
Regulatory Affairs (RA), also called Government Affairs, is a profession within regulated industries, such as pharmaceuticals, medical devices, energy, and banking. Pharmaceutical companies use all the data accumulated during the discovery and development stages in order to register the drug and thus market the drug.
What is the Pharma ROW market?
United States (US) and the EU are the biggest and the most potential markets in the world and are categorized under the regulated markets, whereas the ROW (Rest of the World) market includes all the emerging markets like Brazil (LATAM), Tanzania (Africa), Russia (CIS), Hong Kong (ASIA), etc.
Why do we need regulatory affairs?
The main objective of regulatory affairs is to provide the basis for the assurance of high-quality of food products that can increase consumer’s interest for ensuring efficacy, quality, and safety.
What is a regulated drug?
Answer and Explanation: A regulated drug is one that is researched, manufactured, distributed, and administered under the supervision of regulatory authorities and/or
What is a dossier in regulatory affairs?
A collection of papers giving detailed information about a particular person or subject.
Dossier and Regulatory Affairs:
Dossier helps,
- To create, assemble, update and publish a composite document(s) from various individual document sources and formats.
- Each document or sub-dossier follows its own lifecycle.
What are medical device regulatory affairs?
Regulatory affair is a profession developed from the desire of governments to protect public health by controlling the safety and efficacy of products in areas including pharmaceuticals, veterinary medicines, medical devices, pesticides, agrochemicals, cosmetics, and complementary medicines, and by companies.
What does regulatory framework mean?
Regulatory Framework means any laws, regulations, decrees, and policies officially developed and approved by the government, for the purposes of regulating the SOLID WASTE generation, collection, transport, recycling, reuse, treatment, and disposal.
What is a regulatory process?
The Regulatory Process. What is a regulation? Regulations, or rules, are a primary vehicle with which agencies implement specific laws and general agency objectives. They are specific standards or instructions concerning what can or cannot be done by individuals, businesses, and other organizations.
What are regulatory standards?
Definition of Regulatory Standards: Regulatory Standards means all laws, rules, regulations and Regulatory Authority advisory opinions or orders applicable to the manufacturing, marketing, sale, reimbursement and/or pricing of any Products.
What are the statutory and regulatory requirements?
Both statutory requirements and regulatory requirements are those requirements that are required by law. Statutory refers to laws passed by a state and/or central government, while regulatory refers to a rule issued by a regulatory body appointed by a state and/or central government.
What is the purpose of regulatory compliance?
In general, compliance means conforming to a rule, such as a specification, policy, standard or law. Regulatory compliance describes the goal that organizations aspire to achieve in their efforts to ensure that they are aware of and take steps to comply with relevant laws, policies, and regulations.
What Are The Procedures For the Approval Of Drug In the EU?
- Centralized Procedure (CP)
- Decentralized Procedure (DCP)
- Mutual Recognition Procedure (MRP)
- National Procedure (NP)
What Is The Full Form of the Abbreviation, CEP?
Certificate of Suitability to the monographs of the European Pharmacopoeia (or) Certificate of suitability of monographs of the European Pharmacopoeia (or) Certification of the suitability of European Pharmacopoeia monographs.
It is also informally referred to as the Certificate of Suitability (COS)
What is a CEP?
It is the certificate that is issued by the Certification of Substances Division of the EuropeanDirectorate for the Quality of Medicines (EDQM), when the manufacturer of a substance provides proof that the quality of the substance is suitably controlled by the relevant monographs of the European Pharmacopoeia.
What is a dossier in regulatory affairs?
Regulatory Dossier means all regulatory documents and filings registered with a Drug Regulatory Authority for a Marketing Authorisation containing the administrative, safety, efficacy, quality, non-clinical and clinical data and CMC data for the Drug Product as it may change from time to time.
What are the ICH Guidelines to be Referred for the Preparation of Registration Dossiers/applications of Medicines (with Respect To Format and Contents In Each Module)?
M4 Guideline
M4Q Guideline
M4S Guideline
M4E Guideline
0 Comments